{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.12.1086",
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1086",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "2.16.840.1.113883.3.464.1003.110.12.1086"
  } ],
  "version": "20190315",
  "name": "HibVaccine(4doseschedule)Administered",
  "title": "Hib Vaccine (4 dose schedule) Administered",
  "status": "active",
  "experimental": false,
  "publisher": "NLM",
  "expansion": {
    "identifier": "20220505",
    "timestamp": "2022-08-16T11:47:48-06:00",
    "contains": [ {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90644",
      "display": "Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90648",
      "display": "Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90698",
      "display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "310306005",
      "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "310307001",
      "display": "Administration of second dose of Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "310308006",
      "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "312870000",
      "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "414001002",
      "display": "Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "414259000",
      "display": "Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "415507003",
      "display": "Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "415712004",
      "display": "Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
    } ]
  }
}